نتایج جستجو برای: ca19

تعداد نتایج: 1202  

2013
Sukhwinder Kaur Subhankar Chakraborty Michael J. Baine Kavita Mallya Lynette M. Smith Aaron Sasson Randall Brand Sushovan Guha Maneesh Jain Uwe Wittel Shailender K. Singh Surinder K. Batra

Pancreatic cancer (PC) is lethal malignancy with very high mortality rate. Absence of sensitive and specific marker(s) is one of the major factors for poor prognosis of PC patients. In pilot studies using small set of patients, secreted acute phase proteins neutrophil gelatinase associated lipocalin (NGAL) and TGF-β family member macrophage inhibitory cytokine-1 (MIC-1) are proposed as most pot...

2012
Sayo Kawai Sueli M Oba-Shinjo Lucy S Ito Miyuki Uno Suely K N Marie Nobuyuki Hamajima

BACKGROUND CA19-9 is a tumor marker mainly used for biliary tract, pancreas and colorectum. Since the marker applies usually for adults, the normal range of serum CA19-9 among children has been rarely reported. This is the first study reporting the distribution of serum CA19-9 levels among cancer-free children as well as their parents, taking into account the Lewis and secretor gene polymorphis...

2017
Yongjie Wang Wei Yan Qun Wu Gao Chen Jianmin Zhang

OBJECT The diagnosis of intracranial epidermoid cyst (IEC) relies solely on MRI, which is time and money consuming. The application of tumor biomarkers in IEC has never been systematically studied. Here we screened a group of commonly used tumor biomarkers to assess their diagnostic value in IEC. RESULTS Serum tumor biomarkers were assessed in 42 IECs and 42 paired healthy controls. Only seru...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2014
Jie-Xian Jing Yan Wang Xiao-Qin Xu Ting Sun Bao-Guo Tian Li-Li Du Xian-Wen Zhao Cun-Zhi Han

To evaluate the value of combined detection of serum CEA, CA19-9, CA24-2, AFP, CA72-4, SCC, TPA and TPS for the clinical diagnosis of upper gastrointestinal tract (GIT) cancer and to analyze the efficacy of these tumor markers (TMs) in evaluating curative effects and prognosis. A total of 573 patients with upper GIT cancer between January 2004 and December 2007 were enrolled in this study. Seru...

ژورنال: :مجله دانشگاه علوم پزشکی همدان 0
محمد جعفری mohammad jafari

مقدمه و هدف : آدنوکارسینوم معده یکی از بدخیمی های شایع می باشد و بر اساس آمارهای موجود شیوع آن در ایران پس از سرطان مری در درجه دوم قرار دارد. با توجه به شیوع و شدت این بدخیمی آنچه که بیشتر اهمیت دارد مسأله تشخیص زودرس و جراحی به موقع این تومور است . بهمین منظور این مطالعه با هدف تعیین حساسیت و ویژگی آزمایش ca19-9 در تشخیص آدنوکارسینومای معده انجام گرفت. روش کار : این پژوهش از نوع مطالعه توصیفی...

2018
Jionghuang Chen Ting Zhao Shengnan Jia Senhao Zhou Liangjing Zhou Shaowen Wang Guoping Ding Guixing Jiang Liping Cao

Background: P38α is a ubiquitous protein kinase, which plays diverse roles in cancers. Surprisingly, P38α functions vary markedly in different cancers (e.g., cancer suppressor vs cancer promoter). However, there is no report on the expression of P38α, the family's most important member, in pancreatic ductal adenocarcinoma (PDAC) and its association with clinicoathological parameters and patient...

2006
Hisashi Narimatsu Hiroko Iwasaki Fumiaki Nakayama Yuzuru Ikehara Takashi Kudo Shoko Nishihara Kokichi Sugano Hisanao Okura Shin Fujita Setsuo Hirohashi

The effect of doses of the secretor (Se) and Lewis (Le} genes on the serum levels of CA19-9 and DU-PAN-2 was investigated in 400 normal individuals. It was clearly demonstrated that the Se gene dosage negatively affected both the CA19-9 and DU-PAN-2 values, whereas the Le gene dosage positively affected the CA19-9 value and negatively affected the DU-PAN-2 value. The 400 normal individuals were...

2015
Darragh P. O'Brien Neomal S. Sandanayake Claire Jenkinson Aleksandra Gentry Sophia Apostolidou Evangelia-Ourania Fourkala Stephane Camuzeaux Oleg Blyuss Ian J. Jacobs Usha Eithne Costello Stephen P. Pereira John F. Timms

Purpose: Biomarkers for the early detection of pancreatic cancer are urgently needed. The primary objective of this study was to evaluatewhether increased levels of serumCA19-9, CA125, CEACAM1, and REG3A are present before clinical presentation of pancreatic cancer and to assess the performance of combined markers for early detection and prognosis. Experimental Design: This nested case–control ...

2017
Zhao Ma Xianxian Wu Bo Xu Hongjing Jiang Peng Tang Jie Yue Mingquan Ma Chuangui Chen Hongdian Zhang Zhentao Yu

The number and range of lymph node metastasis (LNM) are critical prognostic factors in esophageal squamous cell carcinoma (ESCC). Preoperative serum biomarkers are reported to be associated with LNM. However, whether these markers can precisely predict the extent of LNM is not known. The aim of this study was to evaluate the predictive value of preoperative serum SCC-Ag, Cyfra21-1, CEA, CA19-9 ...

Journal: :Journal of clinical pathology 2015
Daniel Reitz Armin Gerger Julia Seidel Peter Kornprat Hellmut Samonigg Michael Stotz Joanna Szkandera Martin Pichler

AIMS Tumour markers including carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9 (CA19-9) are frequently determined at the time of diagnosis in patients with pancreatic cancer. Several studies indicate a prognostic relevance of these markers in pancreatic cancer, but space for improvement with regard to the predictive accuracy and ability is given. In this work, the main focus is on ma...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید